<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Methaqualone - Complete Profile</title>
    <link rel="stylesheet" href="/style.css">
</head>

<body>
  <body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/" class="site-title">Dyo's Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/">Home</a>
          </li>
          <li>
            <a href="/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/about/">About</a>
          </li>
          <li>
            <a href="/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/depressants/">Depressants</a> ‚Üí <span>Methaqualone</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üí§ Methaqualone</h1>
        <h2 class="chemical-name">2-Methyl-3-(2-methylphenyl)quinazolin-4(3H)-one</h2>
          <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Methaqualone" 
                data-category="Depressants" 
                data-chemical="2-Methyl-3-(2-methylphenyl)quinazolin-4(3H)-one">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Brand Names</h4>
              <span>Quaalude</span> ‚Ä¢ <span>Sopor</span> ‚Ä¢ <span>Parest</span> ‚Ä¢ <span>Somnafac</span> ‚Ä¢ <span>Optimil</span>
            </div>
            <div class="name-category">
              <h4>Street Names</h4>
              <span>Ludes</span> ‚Ä¢ <span>Disco Biscuits</span> ‚Ä¢ <span>Lemmons</span> ‚Ä¢ <span>714s</span> ‚Ä¢ <span>Sopers</span>
            </div>
            <div class="name-category">
              <h4>Slang Terms</h4>
              <span>Wallbangers</span> ‚Ä¢ <span>Bandits</span> ‚Ä¢ <span>Quas</span> ‚Ä¢ <span>Sopes</span> ‚Ä¢ <span>Love Drug</span>
            </div>
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>Methaqualone HCl</span> ‚Ä¢ <span>2-Methylquinazolone</span> ‚Ä¢ <span>Cateudyl</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category dangerous">Sedative-Hypnotic</span>
          <span class="legal-status schedule-1">Schedule I</span>
          <span class="duration long">6-10 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/methaqualone.jpg" alt="Quaalude pills and molecular structure diagram" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÅ‚ÇÜH‚ÇÅ‚ÇÑN‚ÇÇO</p>
            <p>MW: 250.29 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure Methaqualone (HCl salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> White to off-white crystalline powder</li>
            <li><strong>Texture:</strong> Fine powder or granular crystals</li>
            <li><strong>Odor:</strong> Slightly acrid, chemical smell</li>
            <li><strong>Taste:</strong> Bitter, metallic aftertaste</li>
            <li><strong>Solubility:</strong> Slightly soluble in water, soluble in alcohol</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Historical Street Forms (1960s-1980s)</h4>
          <ul>
            <li><strong>Quaalude 300mg:</strong> White scored tablets with "Lemmon 714" imprint</li>
            <li><strong>Sopor 300mg:</strong> Orange/red tablets, often counterfeited</li>
            <li><strong>Generic tablets:</strong> Various colors, often white or yellow</li>
            <li><strong>Powder form:</strong> Raw methaqualone, extremely rare</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Modern Counterfeits (Extremely Dangerous)</h4>
          <p><strong>Fake "Quaaludes":</strong> Contain benzodiazepines, barbiturates, diphenhydramine, or fentanyl</p>
          <p><strong>Never assume:</strong> Any tablet claiming to be methaqualone is almost certainly fake</p>
          <p><strong>Lethal risk:</strong> Fentanyl-contaminated fakes causing overdose deaths</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Historical Dosage Information</h3>
      <div class="dosage-warning">
        <p><strong>‚ö†Ô∏è CRITICAL WARNING:</strong> Methaqualone is no longer legally manufactured anywhere in the world. Any substance sold as "Quaaludes" today is counterfeit and potentially lethal. This information is for historical reference only.</p>
      </div>
      
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">75-150mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">150-225mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">225-300mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">300-450mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Overdose Risk</span>
          <span class="dose-amount">450mg+</span>
          <div class="dose-bar dangerous"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Historical Dosage Considerations</h4>
        <ul>
          <li><strong>Therapeutic dose:</strong> 150-300mg for insomnia (1960s medical use)</li>
          <li><strong>Recreational dose:</strong> 300-450mg (extremely dangerous)</li>
          <li><strong>Lethal dose:</strong> As low as 8g, but highly variable</li>
          <li><strong>Tolerance:</strong> Develops rapidly with repeated use</li>
          <li><strong>Cross-tolerance:</strong> With other GABA depressants</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Fatal Warning:</strong> Methaqualone has an extremely narrow therapeutic window. The difference between intoxication and fatal overdose is dangerously small, especially when combined with alcohol.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile (Historical)</h3>
      
      <div class="effects-timeline">
        <h4>Timeline</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-1:00</span>
          <span class="effect">Onset - relaxation, mild euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+1:00-4:00</span>
          <span class="effect">Peak - deep sedation, disinhibition</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Plateau - continued sedation, impairment</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-24:00</span>
          <span class="effect">Comedown - grogginess, hangover effects</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Historical "Positive" Effects</h4>
          <ul>
            <li>Deep relaxation and sedation</li>
            <li>Euphoria (at lower doses)</li>
            <li>Disinhibition and sociability</li>
            <li>Sleep induction</li>
            <li>Reduced anxiety</li>
            <li>Muscle relaxation</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Dangerous Side Effects</h4>
          <ul>
            <li>Severe respiratory depression</li>
            <li>Loss of motor coordination</li>
            <li>Slurred speech</li>
            <li>Memory impairment</li>
            <li>Paradoxical agitation</li>
            <li>Vomiting and aspiration risk</li>
            <li>Coma and death (overdose)</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Methaqualone is a positive allosteric modulator of GABA-A receptors, particularly those containing Œ≤1 subunits. Unlike barbiturates, it doesn't directly activate GABA receptors but enhances the binding affinity and efficacy of endogenous GABA. This results in increased chloride ion influx, neuronal hyperpolarization, and CNS depression.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>GABA-A receptors (Œ≤1 subunit)</strong></span>
            <span class="affinity">High selectivity</span>
            <span class="function">Primary sedative, anxiolytic, muscle relaxant effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>GABA-A receptors (Œ≤2/Œ≤3)</strong></span>
            <span class="affinity">Lower affinity</span>
            <span class="function">Additional CNS depression</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Voltage-gated sodium channels</strong></span>
            <span class="affinity">Moderate inhibition</span>
            <span class="function">Anticonvulsant properties, membrane stabilization</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Adenosine receptors</strong></span>
            <span class="affinity">Weak interaction</span>
            <span class="function">Sleep-promoting effects</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> Hepatic oxidation via CYP450 enzymes</p>
          <p><strong>Active metabolites:</strong> 2-methylquinazolin-4-one (less active)</p>
          <p><strong>Half-life:</strong> 20-40 hours (extremely long)</p>
          <p><strong>Bioavailability:</strong> ~80% oral administration</p>
          <p><strong>Peak plasma:</strong> 1-3 hours after oral dose</p>
          <p><strong>Duration:</strong> 6-10 hours acute effects, 24+ hours impairment</p>
        </div>

        <h4>Tolerance & Dependence Mechanisms</h4>
        <div class="dependence-info">
          <p><strong>Physical dependence:</strong> Develops within weeks of regular use</p>
          <p><strong>Tolerance:</strong> Rapid development requiring dose escalation</p>
          <p><strong>Withdrawal syndrome:</strong> Life-threatening seizures, delirium tremens-like symptoms</p>
          <p><strong>Cross-tolerance:</strong> With barbiturates, benzodiazepines, alcohol</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Paradoxical effects:</strong> Can cause agitation and delirium at high doses</li>
          <li><strong>REM suppression:</strong> Dramatically reduces REM sleep</li>
          <li><strong>Respiratory depression:</strong> More severe than benzodiazepines</li>
          <li><strong>Long half-life:</strong> Leads to dangerous accumulation with repeated dosing</li>
          <li><strong>Narrow therapeutic index:</strong> Small margin between effective and toxic doses</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® EXTREME DANGER WARNINGS</h4>
          <ul>
            <li><strong>No safe use:</strong> Methaqualone is inherently dangerous</li>
            <li><strong>Respiratory failure:</strong> Can cause fatal breathing depression</li>
            <li><strong>Alcohol synergy:</strong> Potentially lethal combination</li>
            <li><strong>Overdose risk:</strong> Narrow margin between intoxication and death</li>
            <li><strong>Modern counterfeits:</strong> Often contain fentanyl - immediate death risk</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è If Encountered (Historical Context)</h4>
          <ul>
            <li>Never combine with alcohol or other depressants</li>
            <li>Have naloxone available (for fentanyl-contaminated fakes)</li>
            <li>Never use alone - have sober supervision</li>
            <li>Start with extremely small test doses</li>
            <li>Avoid driving or operating machinery for 24+ hours</li>
            <li>Be aware of delayed onset and long duration</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>Never use if you have:</strong> Respiratory conditions, sleep apnea, liver disease, kidney problems, history of substance abuse, depression, or are taking any other CNS depressants.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ LETHAL COMBINATIONS</h4>
          <ul>
            <li><strong>Alcohol:</strong> Massively increased respiratory depression - frequent cause of death</li>
            <li><strong>Opioids:</strong> Synergistic respiratory depression, guaranteed overdose risk</li>
            <li><strong>Barbiturates:</strong> Additive CNS depression, coma, death</li>
            <li><strong>Benzodiazepines:</strong> Dangerous respiratory depression</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Dangerous</h4>
          <ul>
            <li><strong>Antihistamines:</strong> Increased sedation, anticholinergic effects</li>
            <li><strong>Muscle relaxants:</strong> Additive CNS depression</li>
            <li><strong>Antipsychotics:</strong> Enhanced sedation, respiratory risk</li>
            <li><strong>Sleep medications:</strong> Dangerous over-sedation</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Extreme Caution</h4>
          <ul>
            <li><strong>MAOIs:</strong> Unpredictable interactions</li>
            <li><strong>Tricyclic antidepressants:</strong> Enhanced sedation</li>
            <li><strong>Cannabis:</strong> Increased sedation, memory impairment</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Schedule I</strong> - Completely illegal since 1984. No medical use permitted. Manufacturing, possession, or distribution carries severe federal penalties.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Class B</strong> - Controlled since 1973. Up to 5 years for possession, 14 years for supply.</p>
          </div>
          <div class="jurisdiction">
            <h4>üåç International</h4>
            <p><strong>UN Convention:</strong> Schedule II internationally controlled substance. Banned for medical use worldwide by 1980s.</p>
          </div>
          <div class="jurisdiction">
            <h4>üáÆüá≥ India</h4>
            <p><strong>Special case:</strong> Small-scale illegal manufacturing still occurs, exported to Africa and Middle East</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Medical Status</h4>
          <p>Methaqualone has no accepted medical use anywhere in the world as of 2024. It was removed from medical practice due to its high abuse potential, narrow therapeutic window, and availability of safer alternatives like benzodiazepines.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Cultural Impact</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1951</span>
          <p>Synthesized in India by Indra Kishore Kacker and Zakir Husain</p>
        </div>
        <div class="history-event">
          <span class="year">1962</span>
          <p>Introduced as prescription sleep aid "Quaalude" by William H. Rorer Inc.</p>
        </div>
        <div class="history-event">
          <span class="year">1965-1975</span>
          <p>Peak medical use - prescribed for insomnia and anxiety</p>
        </div>
        <div class="history-event">
          <span class="year">1970s</span>
          <p>Becomes recreational drug of choice in disco culture - "disco biscuits"</p>
        </div>
        <div class="history-event">
          <span class="year">1973</span>
          <p>Moved to Schedule II due to abuse reports</p>
        </div>
        <div class="history-event">
          <span class="year">1984</span>
          <p>Emergency rescheduled to Schedule I after widespread abuse</p>
        </div>
        <div class="history-event">
          <span class="year">1985</span>
          <p>Legal manufacturing ceases in United States</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>Illegal production shifts to South Africa and India</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Cultural Legacy</h4>
        <p>Methaqualone became the defining drug of 1970s hedonistic culture, particularly in disco scenes. Its reputation for enhancing sexual experiences while causing profound disinhibition made it both sought after and notorious. The drug's association with celebrity overdoses and sexual assault led to its demonization and ultimate prohibition.</p>
        
        <h4>The "Quaalude Era"</h4>
        <p>Between 1965-1985, methaqualone represented the pinnacle of pharmaceutical hedonism. Unlike other depressants, it provided euphoria alongside sedation, making it uniquely appealing for recreational use. This same property made it extraordinarily dangerous and ultimately led to its worldwide ban.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Historical Research & Modern Context</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Medical Research (Discontinued)</h4>
          <p>All legitimate medical research on methaqualone ceased by the 1980s due to its poor safety profile and high abuse potential. Safer alternatives like benzodiazepines rendered it medically obsolete.</p>
        </div>
        
        <div class="research-item">
          <h4>Addiction Studies</h4>
          <p>Historical studies revealed methaqualone's extraordinary addictive potential, with physical dependence developing within weeks and withdrawal syndromes requiring medical supervision to prevent seizures and death.</p>
        </div>
        
        <div class="research-item">
          <h4>Forensic Toxicology</h4>
          <p>Modern research focuses on detecting methaqualone in post-mortem cases and understanding its role in historical overdose deaths. Its long half-life makes detection possible weeks after use.</p>
        </div>
        
        <div class="research-item">
          <h4>Counterfeit Analysis</h4>
          <p>Current research analyzes fake "Quaaludes" to identify dangerous adulterants like fentanyl. This work is crucial for harm reduction in communities where counterfeit methaqualone is sold.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Resources & Support</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Emergency Services</h4>
        <ul>
          <li><strong>Overdose Emergency:</strong> Call 911 immediately</li>
          <li><strong>Poison Control:</strong> 1-800-222-1222 (US)</li>
          <li><strong>Crisis Support:</strong> National Suicide Prevention Lifeline</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Historical Information</h4>
        <ul>
          <li><a href="https://erowid.org/">Erowid</a> - Historical reports and information</li>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - Comprehensive substance data</li>
          <li><a href="https://www.ncbi.nlm.nih.gov/">PubMed</a> - Historical medical literature</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Addiction Treatment</h4>
        <ul>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Treatment facility locator</li>
          <li><a href="https://na.org/">Narcotics Anonymous</a> - Peer support</li>
          <li><a href="https://www.smart-recovery.org/">SMART Recovery</a> - Science-based recovery</li>
        </ul>
      </div>
    </div>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/js/lunr.min.js"></script>
    <script src="/assets/js/search.js"></script>
    <script src="/assets/js/substance-integration.js"></script>
</body>
</html>